Mean Number of Platelet and RBC Transfusions Per Treatment Cycle in Group A Compared With Group B and the Nonbleeding Subgroup of B Patients
| . | Group A . | Group B . | Group B4-150 . | P Value . |
|---|---|---|---|---|
| Apheresis plate | 3.0 (0-16) | 4.8 (0-33) | 4.4 (0-23) | A/B < .05 |
| lets | A/B4-150 < .05 | |||
| Pooled random donor platelet concentrates | 15.4 (0-152) | 25.4 (0-188) | 23.2 (0-160) | A/B < .01 A/B4-150 < .01 |
| RBC packs | 7.3 (0-22) | 8.3 (2-28) | 7.6 (2-28) | A/B NS |
| A/B4-150 NS |
| . | Group A . | Group B . | Group B4-150 . | P Value . |
|---|---|---|---|---|
| Apheresis plate | 3.0 (0-16) | 4.8 (0-33) | 4.4 (0-23) | A/B < .05 |
| lets | A/B4-150 < .05 | |||
| Pooled random donor platelet concentrates | 15.4 (0-152) | 25.4 (0-188) | 23.2 (0-160) | A/B < .01 A/B4-150 < .01 |
| RBC packs | 7.3 (0-22) | 8.3 (2-28) | 7.6 (2-28) | A/B NS |
| A/B4-150 NS |
Abbreviation: NS, not significant.
Seven patients with WHO grade 3 and 4 bleeding of group B were excluded.